Theoretical study of chemical reactivity descriptors of some repurposed drugs for COVID-19

被引:11
|
作者
Morad, Razieh [1 ]
Akbari, Mahmood [2 ]
Maaza, Malik [1 ,2 ]
机构
[1] Univ South Africa UNISA, Coll Grad Studies, UNESCO UNISA iTLABS Africa Chair Nanosci & Nanotec, Pretoria, South Africa
[2] Natl Res Fdn, Mat Res Div, iThemba LABS, Nanosci African Network NANOAFNET, ZA-7129 Somerset West, South Africa
关键词
D O I
10.1557/s43580-023-00590-6
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
This study focuses on computational studies of chemical reactivity descriptors of some proposed drugs for COVID-19. Density functional theory calculations were used to optimize the structure and investigate the frontier orbitals and the chemical reactivity descriptors of these drugs. The frontier orbitals, which include both the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO), play an essential role in molecular interactions and chemical reactivity of molecule. Polarizability, which determines the response of the susceptibility of a molecule to an approaching charge, is higher in the more complex drugs such as Hydroxychloroquine, Remdesivir, and Ivermectin compare to the smaller drugs. The HOMO and LUMO orbital energies were calculated to obtain the energy gap of the studied drugs, which is in the following order: Favipiravir < Hydroxychloroquine, Remdesivir < Ivermectin < Artesunate < Artemether < Artemisinin. Generally, molecules with a larger energy gap have lower chemical reactivity and higher kinetic stability.
引用
收藏
页码:656 / 660
页数:5
相关论文
共 50 条
  • [41] Potential COVID-19 remedies from repurposed drugs and herbal small RNAs
    Yang, Yang
    Huang, Fengming
    Qiao, Xiangyu
    Chen, Sheng
    Zhang, Cong
    Deng, Xingyu
    Gu, Wentao
    Peng, Ling
    Cao, Mengli
    Jiang, Jingmei
    Gao, George F.
    Liu, Yingxia
    Jiang, Chengyu
    IUBMB LIFE, 2024, 76 (11) : 960 - 971
  • [42] Repurposed Antiviral Drugs for the Treatment of COVID-19: Syntheses, Mechanism of Infection and Clinical Trials
    Paul, Subha Sankar
    Biswas, Goutam
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2021, 21 (09) : 1123 - 1143
  • [43] Enhancement of the IFN-β-induced host signature informs repurposed drugs for COVID-19
    Huang, Chen-Tsung
    Chao, Tai-Ling
    Kao, Han-Chieh
    Pang, Yu-Hao
    Lee, Wen-Hau
    Hsieh, Chiao-Hui
    Chang, Sui-Yuan
    Huang, Hsuan-Cheng
    Juan, Hsueh-Fen
    HELIYON, 2020, 6 (12)
  • [44] A validated UHPLC-MS/MS method for simultaneous quantification of some repurposed COVID-19 drugs in rat plasma: Application to a pharmacokinetic study
    El Azab, Noha F.
    MICROCHEMICAL JOURNAL, 2022, 178
  • [45] Topological Study of Some Covid-19 Drugs by Using Temperature Indices
    Zhen, Wang
    Khalid, Asma
    Ali, Parvez
    Rehman, Haider
    Siddiqui, Muhammad Kamran
    Ullah, Hameed
    POLYCYCLIC AROMATIC COMPOUNDS, 2023, 43 (02) : 1133 - 1144
  • [46] The mouse to man conundrum: Revisiting an old lung injury model to study repurposed drugs for COVID-19 treatment
    Ronit, Andreas
    Plovsing, Ronni R.
    EXPERIMENTAL PHYSIOLOGY, 2024, 109 (06) : 837 - 838
  • [47] Functional respiratory imaging repurposed for COVID-19
    van Es, Josien
    Meijboom, Lilian J.
    THORAX, 2021, 76 (02) : 107 - 107
  • [48] The safety of ivermectin as a repurposed drug for COVID-19
    Wentzel, H.
    Wang, J.
    Dayanamby, A.
    Levi, J.
    Pilkington, V.
    Ellis, L.
    Hill, A.
    HIV MEDICINE, 2021, 22 : 224 - 225
  • [49] Repurposed Tocilizumab in Patients with Severe COVID-19
    Tian, Jianbo
    Zhang, Ming
    Jin, Meng
    Zhang, Fengqin
    Chu, Qian
    Wang, Xiaoyang
    Chen, Can
    Yue, Huihui
    Zhang, Li
    Du, Ronghui
    Zhao, Dong
    Zeng, Zhaofu
    Zhao, Yang
    Liu, Kui
    Wang, Mengmei
    Hu, Ke
    Miao, Xiaoping
    Zhang, Huilan
    JOURNAL OF IMMUNOLOGY, 2021, 206 (03): : 599 - 606
  • [50] Plitidepsin: a Repurposed Drug for the Treatment of COVID-19
    Angel Martinez, Miguel
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (04)